Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)
Clinical trial NCT05030350 · TERMINATED
Trial details
- NCT number
- NCT05030350
- Sponsor
- VistaGen Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2022-09-23
- Enrollment
- 481
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.